Press
· News

POELLATH advises Heal Capital on Final Closing of HealthTech Fund at EUR 100m

Venture capitalist Heal Capital has held the final closing of its first venture capital fund “heal.capital I” with a volume of EUR 100.7m, reaching its target volume of EUR 100m.

Heal Capital is a Berlin-based venture capital investor that promotes companies with a focus on digital innovations for healthcare. Heal.capital I will focus on young HealthTech companies in the fields of diagnostics, therapy and infrastructure. In this segment, heal.capital I is one of the largest venture capital funds in Europe.

POELLATH advised Heal Capital on all contractual, tax and regulatory aspects of the fundstructuring and marketing as well as investor negotiations with the following Berlin Private Funds team:

Press release
Press contact
Services
  • Private Funds
    • Fund Structuring
    • Fund Regulatory Law
    • Investor Advice
    • Fund Tax Law
    • VC Funds
all Services
Professionals
Dr. Philip Schwarz van Berk, LL.M.
Partner
+49 (30) 25353-109 call
all Professionals